First Foundation Advisors’s Eli Lilly LLY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $7.04M | Sell |
5,869
-478
| -8% | -$488K | 0.25% | 66 |
|
|
2026
Q1 | $5.84M | Buy |
6,347
+19
| +0.3% | +$19.3K | 0.24% | 71 |
|
|
2025
Q4 | $6.8M | Buy |
6,328
+384
| +6% | +$367K | 0.26% | 67 |
|
|
2025
Q3 | $4.54M | Buy |
5,944
+358
| +6% | +$266K | 0.17% | 89 |
|
|
2025
Q2 | $4.35M | Buy |
5,586
+3,148
| +129% | +$2.45M | 0.16% | 93 |
|
|
2025
Q1 | $2.01M | Sell |
2,438
-208
| -8% | -$173K | 0.08% | 123 |
|
|
2024
Q4 | $2.04M | Buy |
2,646
+28
| +1% | +$23.2K | 0.08% | 123 |
|
|
2024
Q3 | $2.32M | Sell |
2,618
-167
| -6% | -$150K | 0.09% | 117 |
|
|
2024
Q2 | $2.52M | Buy |
2,785
+57
| +2% | +$45.6K | 0.1% | 108 |
|
|
2024
Q1 | $2.12M | Sell |
2,728
-47
| -2% | -$33.4K | 0.08% | 113 |
|
|
2023
Q4 | $1.62M | Sell |
2,775
-1,840
| -40% | -$1.07M | 0.07% | 132 |
|
|
2023
Q3 | $2.48M | Buy |
4,615
+262
| +6% | +$135K | 0.12% | 111 |
|
|
2023
Q2 | $2.04M | Buy |
4,353
+782
| +22% | +$328K | 0.09% | 127 |
|
|
2023
Q1 | $1.23M | Sell |
3,571
-208
| -6% | -$70.2K | 0.06% | 159 |
|
|
2022
Q4 | $1.38M | Sell |
3,779
-237
| -6% | -$84K | 0.07% | 157 |
|
|
2022
Q3 | $1.3M | Buy |
4,016
+81
| +2% | +$25.7K | 0.06% | 149 |
|
|
2022
Q2 | $1.28M | Sell |
3,935
-60
| -2% | -$18K | 0.06% | 160 |
|
|
2022
Q1 | $1.14M | Buy |
3,995
+328
| +9% | +$84.4K | 0.04% | 181 |
|
|
2021
Q4 | $1.01M | Buy |
3,667
+804
| +28% | +$204K | 0.03% | 200 |
|
|
2021
Q3 | $662K | Buy |
2,863
+726
| +34% | +$179K | 0.02% | 241 |
|
|
2021
Q2 | $491K | Sell |
2,137
-43
| -2% | -$8.64K | 0.02% | 289 |
|
|
2021
Q1 | $407K | Buy |
2,180
+452
| +26% | +$88.4K | 0.02% | 297 |
|
|
2020
Q4 | $292K | Buy |
1,728
+160
| +10% | +$23.9K | 0.01% | 342 |
|
|
2020
Q3 | $232K | Sell |
1,568
-51
| -3% | -$7.89K | 0.01% | 336 |
|
|
2020
Q2 | $266K | Buy |
+1,619
| New | +$249K | 0.01% | 298 |
|
|
2019
Q3 | – | Sell |
-2,990
| Closed | -$331K | – | 366 |
|
|
2019
Q2 | $331K | Sell |
2,990
-479
| -14% | -$56.4K | 0.02% | 261 |
|
|
2019
Q1 | $450K | Buy |
3,469
+390
| +13% | +$47.4K | 0.03% | 229 |
|
|
2018
Q4 | $356K | Buy |
3,079
+64
| +2% | +$7.15K | 0.02% | 301 |
|
|
2018
Q3 | $324K | Sell |
3,015
-285
| -9% | -$28.5K | 0.02% | 278 |
|
|
2018
Q2 | $282K | Sell |
3,300
-550
| -14% | -$45.2K | 0.02% | 271 |
|
|
2018
Q1 | $298K | Sell |
3,850
-1,480
| -28% | -$119K | 0.02% | 264 |
|
|
2017
Q4 | $450K | Hold |
5,330
| – | – | 0.02% | 234 |
|
|
2017
Q3 | $456K | Sell |
5,330
-1,504
| -22% | -$123K | 0.03% | 212 |
|
|
2017
Q2 | $562K | Sell |
6,834
-1,321
| -16% | -$108K | 0.03% | 193 |
|
|
2017
Q1 | $686K | Buy |
8,155
+668
| +9% | +$53.5K | 0.04% | 177 |
|
|
2016
Q4 | $551K | Buy |
7,487
+255
| +4% | +$19K | 0.04% | 188 |
|
|
2016
Q3 | $580K | Buy |
7,232
+100
| +1% | +$8K | 0.04% | 180 |
|
|
2016
Q2 | $562K | Sell |
7,132
-2,414
| -25% | -$182K | 0.04% | 181 |
|
|
2016
Q1 | $687K | Sell |
9,546
-281
| -3% | -$21.3K | 0.05% | 147 |
|
|
2015
Q4 | $828K | Buy |
9,827
+234
| +2% | +$19.4K | 0.06% | 139 |
|
|
2015
Q3 | $803K | Sell |
9,593
-170
| -2% | -$14.4K | 0.07% | 125 |
|
|
2015
Q2 | $815K | Sell |
9,763
-330
| -3% | -$25.1K | 0.06% | 119 |
|
|
2015
Q1 | $733K | Buy |
10,093
+475
| +5% | +$33.8K | 0.06% | 122 |
|
|
2014
Q4 | $664K | Sell |
9,618
-843
| -8% | -$56.9K | 0.06% | 124 |
|
|
2014
Q3 | $678K | Hold |
10,461
| – | – | 0.07% | 119 |
|
|
2014
Q2 | $650K | Buy |
10,461
+799
| +8% | +$47.7K | 0.07% | 109 |
|
|
2014
Q1 | $569K | Buy |
9,662
+92
| +1% | +$5.13K | 0.07% | 93 |
|
|
2013
Q4 | $488K | Buy |
9,570
+130
| +1% | +$6.51K | 0.07% | 103 |
|
|
2013
Q3 | $475K | Hold |
9,440
| – | – | 0.07% | 98 |
|
|
2013
Q2 | $464K | Buy |
+9,440
| New | +$514K | 0.09% | 79 |
|
Other funds holding LLY
First Foundation Advisors's LLY Position: Q2 2026 in Review
First Foundation Advisors reduced its Eli Lilly (LLY) stake by 7.5% in Q2 2026, selling an estimated $488K and leaving 5,869 shares worth $7.04M. The position accounts for 0.25% of the portfolio, ranked #66.
First Foundation Advisors first reported a position in LLY in Q2 2013 and has held it in 50 quarters since. 4,602 funds tracked by Wall St. Rank hold LLY as of Q2 2026.
- First Foundation Advisors held 5,869 shares of Eli Lilly worth $7.04M as of Q2 2026.
- First Foundation Advisors sold 478 Eli Lilly shares in Q2 2026, an estimated $488K.
- Eli Lilly made up 0.25% of First Foundation Advisors's portfolio in Q2 2026, its #66 holding.
- First Foundation Advisors first reported a position in Eli Lilly in Q2 2013 and has held it in 50 quarters since.
- 4,602 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.
Based on First Foundation Advisors's 13F filing for Q2 2026, filed 14 Aug 2026.